Documents & Downloads

Hynic-toc

Octreotide Derivative

Hynic-toc (HYNIC-Tyr3-octreotide) is an octreotide derivative designed for conjugation with radioactive elements, facilitating tumor imaging applications. This compound is instrumental in the synthesis of Radionuclide-Drug Conjugates (RDCs), enabling targeted delivery and visualization of tumors. Its unique structure allows for enhanced binding to somatostatin receptors in cancer cells, supporting various research endeavors in oncological diagnostics and therapeutics.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	257943-19-4
Applications	Octreotide Derivative
Formula	C₅₅H₇₁N₁₃O₁₂S₂
Molecular Weight	1170.36
Synonyms	HYNIC-Tyr3-octreotide

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.